Regenerative Retinal Laser and Light Therapies (RELITE): Proposal of a New Nomenclature, Categorization, and Trial Reporting Standard
Lasers in Surgery and Medicine · 2024-10 · 56 (8) · 693-708
DOI: 10.1002/lsm.23833 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Lasers in Surgery and Medicine, online erschienen am 30.08.2024. Verfasst von Claus von der Burchard und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University of Kiel, University Medical Center of Schleswig-Holstein, Kiel, Germany. Hauptthemen laut MEDLINE: Retinal Diseases, Terminology as Topic. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 157 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Objectives
Numerous laser and light therapies have been developed to induce regenerative processes in the choroid/retinal pigment epithelium (RPE)/photoreceptor complex, leaving the neuroretina undamaged. These therapies are applied to the macula for the treatment of various diseases, most prominently diabetic maculopathy, retinal vein occlusion, central serous chorioretinopathy, and age‐related macular degeneration. However, the abundance of technologies, treatment patterns, and dosimetry protocols has made understanding these therapies and comparing different approaches increasingly complex and challenging. To address this, we propose a new nomenclature system with a clear categorization that will allow for better understanding and comparability between different laser and light modalities. We propose this nomenclature system as an open standard that may be adapted in future toward new technical developments or medical advancements.
Methods
A systematic literature review of reported macular laser and light therapies was conducted. A categorization into a standardized system was proposed and discussed among experts and professionals in the field. This paper does not aim to assess, compare, or evaluate the efficacy of different laser or dosimetry techniques or treatment patterns.
Results
The literature search yielded 194 papers describing laser techniques, 50 studies describing dosimetry, 272 studies with relevant clinical trials, and 82 reviews. Following the common therapeutic aim, we propose “regenerative retinal laser and light therapies (RELITE)” as the general header. We subdivided RELITE into four main categories that refer to the intended physical and biochemical effects of temperature increase (photothermal therapy, PTT), RPE regeneration (photomicrodisruption therapy, PMT), photochemical processes (photochemical therapy, PCT), and photobiomodulation (photobiomodulation therapy, PBT). Further, we categorized the different dosimetry approaches and treatment regimens. We propose the following nomenclature system that integrates the most important parameters to enable understanding and comparability: Pattern—Dosimetry—Exposure Time/Frequency, Duty Cycle/Irradiation Diameter/Wavelength—Subcategory—Category .
Conclusion
Regenerative retinal laser and light therapies are widely used for different diseases and may become valuable in the future. A precise nomenclature system and strict reporting standards are needed to allow for a better understanding, reproduceable and comparable clinical trials, and overall acceptance. We defined categories for a systematic therapeutic goal‐based nomenclature to facilitate future research in this field.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, University of Kiel, University Medical Center of Schleswig-Holstein, Kiel, Germany.
- Institute of Biomedical Optics, University of Luebeck, Luebeck, Germany.
- Department of Ophthalmology, University of Luebeck, University Medical Center of Schleswig-Holstein, Luebeck, Germany.
- Eye Clinic Sulzbach, Knappschaft Hospital Saar, Sulzbach, Germany.
- Department of Ophthalmology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- Hannover Medical School, University Eye Clinic, Hannover, Germany.
ORCID-Profile: Claus von der Burchard, Yoko Miura, Boris Stanzel, Jay Chhablani, Ralf Brinkmann, Jan Tode
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
von der Burchard, C., Miura, Y., Stanzel, B., Chhablani, J., Roider, J., Framme, C., Brinkmann, R., & Tode, J. (2024). Regenerative Retinal Laser and Light Therapies (RELITE): Proposal of a New Nomenclature, Categorization, and Trial Reporting Standard. Lasers in Surgery and Medicine, 56(8), 693-708. https://doi.org/10.1002/lsm.23833
Vancouver
von der Burchard C, Miura Y, Stanzel B, Chhablani J, Roider J, Framme C, et al. Regenerative Retinal Laser and Light Therapies (RELITE): Proposal of a New Nomenclature, Categorization, and Trial Reporting Standard. Lasers in Surgery and Medicine. 2024;56(8):693-708. doi:10.1002/lsm.23833
BibTeX
@article{vonderBurchard2024,
author = {von der Burchard, Claus and Miura, Yoko and Stanzel, Boris and Chhablani, Jay and Roider, Johann and Framme, Carsten and Brinkmann, Ralf and Tode, Jan},
title = {Regenerative Retinal Laser and Light Therapies (RELITE): Proposal of a New Nomenclature, Categorization, and Trial Reporting Standard},
journal = {Lasers in Surgery and Medicine},
year = {2024},
volume = {56},
number = {8},
pages = {693--708},
doi = {10.1002/lsm.23833}
}
EUVIMED